Letter

Clopidogrel

Increasing concordance

BMJ 2009; 338 doi: 10.1136/bmj.b1928 (Published 20 May 2009)
Cite this as: BMJ 2009;338:b1928

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter D Burrill, specialist pharmaceutical adviser for public health1
  1. 1Derbyshire County Primary Care Trust, Chesterfield S41 7PF
  1. peter.burrill{at}derbyshirecountypct.nhs.uk

    Chua and Ignaszewski review the evidence base for clopidogrel in acute coronary syndromes.1 Knowing the number needed to treat and number needed to harm for each trial would …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular